Veterinary Medicine

Breaking

Cellenkos Receives FDA Clearance for CK0802 Phase 2a Trial in Steroid-Refractory GVHD FDA Approves Guardant360 CDx Companion Diagnostic for Pfizer's VEPPANU in ER+/HER2- Breast Cancer RAPS Euro Convergence 2026: Regulatory News - Day 1 Roundup

NewsApr 29, 2026

Zhengye Biotechnology Reports Fiscal 2025 Financial Results for Veterinary Vaccine Business

Zhengye Biotechnology (NASDAQ: ZYBT) announces fiscal year 2025 financial results, highlighting performance in veterinary vaccine manufacturing and research operations.

Dr. Priya Sharma

News by Topic

More News Topics

Press Releases

Analysis by Topic

More Analysis Topics

Whitepapers

Browse

By Region

Directory

By Region

For Suppliers

For Brands

Resources

Popular Topics

More Topics

Browse

About Us

Get in Touch

Quick Actions

Recent Searches

Popular Topics

Suggestions

Zhengye Biotechnology Reports Fiscal 2025 Financial Results for Veterinary Vaccine Business